1.Mushroom Poisoning by Podostroma cornu-damae: A Case Report and Review of the Literature.
Hyung Min YU ; Jiwan KIM ; Seonghui KANG ; Sanghee AN ; Chae Ho LIM ; Hong Ghi LEE ; Kyeong Ryong LEE
Journal of the Korean Society of Emergency Medicine 2013;24(4):469-472
Podostroma cornu-damae is a rare species of fungus belonging to the Hyocreaceae family. Its fruit body is highly toxic, as it contains trichothecene mycotoxins. Unfortunately, it highly resembles Ganoderma lucidum and Cordyceps, well-known health foods; this can lead to poisoning. We experienced such a case of a 42-year old man who received mushroom poisoning by injesting Podostroma cornu-damae. The patient was presented with severe pancytopenia and infection. The patient recovered without any complications after conservative care, antibiotics therapy, and granulocyte colony stimulating factor administration. The most common complications of podostroma cornu-damae intoxication were reported pancytopenia, infection, disseminated intravascular coagulation, acute renal failure, etc. It is important to provide enough fluid therapy, use of antibiotics to infection and granulocyte colony stimulating factor administration.
Acute Kidney Injury
;
Agaricales
;
Anti-Bacterial Agents
;
Colony-Stimulating Factors
;
Cordyceps
;
Disseminated Intravascular Coagulation
;
Fluid Therapy
;
Fruit
;
Fungi
;
Granulocytes
;
Humans
;
Mushroom Poisoning
;
Mycotoxins
;
Pancytopenia
;
Reishi
;
Trichothecenes
2.Polypharmacy and Elevated Risk of Severe Adverse Events in Older Adults Based on the Korea Institute of Drug Safety and Risk Management-Korea Adverse Event Reporting System Database
Grace Juyun KIM ; Ji Sung LEE ; Sujung JANG ; Seonghui LEE ; Seongwoo JEON ; Suehyun LEE ; Ju Han KIM ; Kye Hwa LEE
Journal of Korean Medical Science 2024;39(28):e205-
Background:
Older adults are at a higher risk of severe adverse drug events (ADEs) because of multimorbidity, polypharmacy, and lower physiological function. This study aimed to determine whether polypharmacy, defined as the use of ≥ 5 active drug ingredients, was associated with severe ADEs in this population.
Methods:
We used ADE reports from the Korea Institute of Drug Safety and Risk Management-Korea Adverse Event Reporting System Database, a national spontaneous ADE report system, from 2012 to 2021 to examine and compare the strength of association between polypharmacy and severe ADEs in older adults (≥ 65 years) and younger adults (20–64 years) using disproportionality analysis.
Results:
We found a significant association between severe ADEs of cardiac and renal/ urinary Medical Dictionary for Regulatory Activities System Organ Classes (MedDRA SOC) with polypharmacy in older adults. Regarding individual-level ADEs included in these MedDRA SOCs, acute cardiac arrest and renal failure were more significantly associated with polypharmacy in older adults compared with younger adults.
Conclusion
The addition of new drugs to the regimens of older adults warrants close monitoring of renal and cardiac symptoms.
3.Polypharmacy and Elevated Risk of Severe Adverse Events in Older Adults Based on the Korea Institute of Drug Safety and Risk Management-Korea Adverse Event Reporting System Database
Grace Juyun KIM ; Ji Sung LEE ; Sujung JANG ; Seonghui LEE ; Seongwoo JEON ; Suehyun LEE ; Ju Han KIM ; Kye Hwa LEE
Journal of Korean Medical Science 2024;39(28):e205-
Background:
Older adults are at a higher risk of severe adverse drug events (ADEs) because of multimorbidity, polypharmacy, and lower physiological function. This study aimed to determine whether polypharmacy, defined as the use of ≥ 5 active drug ingredients, was associated with severe ADEs in this population.
Methods:
We used ADE reports from the Korea Institute of Drug Safety and Risk Management-Korea Adverse Event Reporting System Database, a national spontaneous ADE report system, from 2012 to 2021 to examine and compare the strength of association between polypharmacy and severe ADEs in older adults (≥ 65 years) and younger adults (20–64 years) using disproportionality analysis.
Results:
We found a significant association between severe ADEs of cardiac and renal/ urinary Medical Dictionary for Regulatory Activities System Organ Classes (MedDRA SOC) with polypharmacy in older adults. Regarding individual-level ADEs included in these MedDRA SOCs, acute cardiac arrest and renal failure were more significantly associated with polypharmacy in older adults compared with younger adults.
Conclusion
The addition of new drugs to the regimens of older adults warrants close monitoring of renal and cardiac symptoms.
4.Polypharmacy and Elevated Risk of Severe Adverse Events in Older Adults Based on the Korea Institute of Drug Safety and Risk Management-Korea Adverse Event Reporting System Database
Grace Juyun KIM ; Ji Sung LEE ; Sujung JANG ; Seonghui LEE ; Seongwoo JEON ; Suehyun LEE ; Ju Han KIM ; Kye Hwa LEE
Journal of Korean Medical Science 2024;39(28):e205-
Background:
Older adults are at a higher risk of severe adverse drug events (ADEs) because of multimorbidity, polypharmacy, and lower physiological function. This study aimed to determine whether polypharmacy, defined as the use of ≥ 5 active drug ingredients, was associated with severe ADEs in this population.
Methods:
We used ADE reports from the Korea Institute of Drug Safety and Risk Management-Korea Adverse Event Reporting System Database, a national spontaneous ADE report system, from 2012 to 2021 to examine and compare the strength of association between polypharmacy and severe ADEs in older adults (≥ 65 years) and younger adults (20–64 years) using disproportionality analysis.
Results:
We found a significant association between severe ADEs of cardiac and renal/ urinary Medical Dictionary for Regulatory Activities System Organ Classes (MedDRA SOC) with polypharmacy in older adults. Regarding individual-level ADEs included in these MedDRA SOCs, acute cardiac arrest and renal failure were more significantly associated with polypharmacy in older adults compared with younger adults.
Conclusion
The addition of new drugs to the regimens of older adults warrants close monitoring of renal and cardiac symptoms.
5.Polypharmacy and Elevated Risk of Severe Adverse Events in Older Adults Based on the Korea Institute of Drug Safety and Risk Management-Korea Adverse Event Reporting System Database
Grace Juyun KIM ; Ji Sung LEE ; Sujung JANG ; Seonghui LEE ; Seongwoo JEON ; Suehyun LEE ; Ju Han KIM ; Kye Hwa LEE
Journal of Korean Medical Science 2024;39(28):e205-
Background:
Older adults are at a higher risk of severe adverse drug events (ADEs) because of multimorbidity, polypharmacy, and lower physiological function. This study aimed to determine whether polypharmacy, defined as the use of ≥ 5 active drug ingredients, was associated with severe ADEs in this population.
Methods:
We used ADE reports from the Korea Institute of Drug Safety and Risk Management-Korea Adverse Event Reporting System Database, a national spontaneous ADE report system, from 2012 to 2021 to examine and compare the strength of association between polypharmacy and severe ADEs in older adults (≥ 65 years) and younger adults (20–64 years) using disproportionality analysis.
Results:
We found a significant association between severe ADEs of cardiac and renal/ urinary Medical Dictionary for Regulatory Activities System Organ Classes (MedDRA SOC) with polypharmacy in older adults. Regarding individual-level ADEs included in these MedDRA SOCs, acute cardiac arrest and renal failure were more significantly associated with polypharmacy in older adults compared with younger adults.
Conclusion
The addition of new drugs to the regimens of older adults warrants close monitoring of renal and cardiac symptoms.
6.Pulmonary Cryptococcosis in a Patient with Ankylosing Spondylitis treated with Etanercept.
Chae Ho LIM ; Sang Heon LEE ; Ho Youn KIM ; Wan Seop KIM ; Seonghui KANG ; Se Woong KWON ; Jiwan KIM ; Soo Youn PARK ; Sang Hee AN ; Hyung Min YU ; Hae Rim KIM
Journal of Rheumatic Diseases 2014;21(4):214-218
Ankylosing spondylitis (AS) is a chronic inflammatory disorder, commonly characterized by inflammation of axial skeleton and development of enthesopathies. Tumor necrosis factor inhibitors (TNFi) shows good therapeutic responses in AS patients without good response to non-steroidal anti-inflammatory drugs. Although TNFi are relatively safe for AS patients, serious opportunistic infections, including tuberculosis and fungal infection, could develop. Here, according to our knowledge, we report a first Korean case of pulmonary cryptococcosis in a patient with AS treated with etanercept. A 64 year-old man with AS visited due to a newly appeared pulmonary nodule on a routine chest radiography. He had been administered etanercept for 5 months. Histologic findings of the lung nodule showed characteristic features of cryptococcosis. Etanercept was discontinued and oral fluconazole was administrated, as there was no evidence of central nervous system involvement. After 7 months of treatment, chest CT showed an improvement of the pulmonary lesion.
Central Nervous System
;
Cryptococcosis*
;
Fluconazole
;
Humans
;
Inflammation
;
Lung
;
Opportunistic Infections
;
Radiography
;
Rheumatic Diseases
;
Skeleton
;
Spondylitis, Ankylosing*
;
Thorax
;
Tomography, X-Ray Computed
;
Tuberculosis
;
Tumor Necrosis Factor-alpha
;
Etanercept
7.Perception and Attitudes of Korean Obstetricians about Maternal Influenza Vaccination.
Ji Yun NOH ; Yu Bin SEO ; Joon Young SONG ; Won Suk CHOI ; Jacob LEE ; Eunju JUNG ; Seonghui KANG ; Min Joo CHOI ; Jiho JUN ; Jin Gu YOON ; Saem Na LEE ; Hakjun HYUN ; Jin Soo LEE ; Hojin CHEONG ; Hee Jin CHEONG ; Woo Joo KIM
Journal of Korean Medical Science 2016;31(7):1063-1068
Pregnant women are prioritized to receive influenza vaccination. However, the maternal influenza vaccination rate has been low in Korea. To identify potential barriers for the vaccination of pregnant women against influenza, a survey using a questionnaire on the perceptions and attitudes about maternal influenza vaccination was applied to Korean obstetricians between May and August of 2014. A total of 473 respondents participated in the survey. Most respondents (94.8%, 442/466) recognized that influenza vaccination was required for pregnant women. In addition, 92.8% (410/442) respondents knew that the incidence of adverse events following influenza vaccination is not different between pregnant and non-pregnant women. However, 26.5% (124/468) obstetricians strongly recommended influenza vaccination to pregnant women. The concern about adverse events following influenza vaccination was considered as a major barrier for the promotion of maternal influenza vaccination by healthcare providers. Providing professional information and education about maternal influenza vaccination will enhance the perception of obstetricians about influenza vaccination to pregnant women and will be helpful to improve maternal influenza vaccination coverage in Korea.
Asian Continental Ancestry Group
;
Cross-Sectional Studies
;
Female
;
*Health Knowledge, Attitudes, Practice
;
Humans
;
Influenza Vaccines/*immunology
;
Influenza, Human/*prevention & control
;
Maternal Welfare
;
*Perception
;
Physicians/*psychology
;
Pregnancy
;
Pregnant Women
;
Republic of Korea
;
Surveys and Questionnaires
;
Vaccination
8.Campylobacter jejuni Bacteremia in a Liver Cirrhosis Patient and Review of Literature: A Case Study.
Jin Gu YOON ; Saem Na LEE ; Hak Jun HYUN ; Min Joo CHOI ; Ji Ho JEON ; Eunju JUNG ; Seonghui KANG ; Jeeyong KIM ; Ji Yun NOH ; Won Suk CHOI ; Joon Young SONG ; Hee Jin CHEONG ; Woo Joo KIM
Infection and Chemotherapy 2017;49(3):230-235
Campylobacter infection causes gastrointestinal symptoms such as abdominal pain or diarrhea. Occasionally, Campylobacter bacteremia affects immunocompromised patients; however, serious outcomes are known to be rare. Here, we present a case of a patient with Campylobacter bacteremia who had underlying liver cirrhosis. The patient had fever and diarrhea. These symptoms subsided after treatment with cefotaxime. Campylobacter jejuni was isolated in the blood culture after 10 days. In addition, previously reported cases of Campylobacter bacteremia in Asian countries were reviewed with respect to antimicrobial sensitivities.
Abdominal Pain
;
Asian Continental Ancestry Group
;
Bacteremia*
;
Campylobacter Infections
;
Campylobacter jejuni*
;
Campylobacter*
;
Cefotaxime
;
Diarrhea
;
Fever
;
Humans
;
Immunocompromised Host
;
Liver Cirrhosis*
;
Liver*